Nova Patents
IL221193D0

Human monoclonal antibodies against cd20

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

85 members in 26 offices

This recordMember, by publication datePriority claim16 more offices are in the list below

Priority claims9

Priority claims
DocumentOfficeKindDate
41916302United States of AmericaP
46002803United States of AmericaP
0333057United States of AmericaW
60419163–––
60460028–––
PCTUS2003033057–––
US20020419163P–––
US20030460028P–––
WO2003US33057–––

Members85

Family members, oldest first
DocumentOfficeKind
CA2502552A1CanadaA1
CA3029035A1CanadaA1
WO2004035607A2World Intellectual Property Organization (WIPO)A2
AU2003301445A1AustraliaA1
WO2004035607A8World Intellectual Property Organization (WIPO)A8
WO2004035607A3World Intellectual Property Organization (WIPO)A3
US2004167319A1United States of AmericaA1
KR20050049552ARepublic of KoreaA
EP1558648A2European Patent Office (EPO)A2
BR0315295ABrazilA
MXPA05004022AMexicoA
PL376351A1PolandA1
CN1729203AChinaA
EP1558648A4European Patent Office (EPO)A4
HK1077590A1Hong Kong, ChinaA1
EA200500679A1Eurasian Patent Organization (EAPO)A1
JP2006507844AJapanA
KR20080090565ARepublic of KoreaA
IL167851D0IsraelD0
KR20090088973ARepublic of KoreaA
KR100932340B1Republic of KoreaB1
JP2010042002AJapanA
KR100944575B1Republic of KoreaB1
NZ568769ANew ZealandA
KR20100050587ARepublic of KoreaA
CN101928344AChinaA
KR20110017020ARepublic of KoreaA
UA93478C2UkraineC2
JP4662473B2JapanB2
EP2316856A1European Patent Office (EPO)A1
EP2330130A1European Patent Office (EPO)A1
NZ581541ANew ZealandA
KR20110140142ARepublic of KoreaA
EP1558648B1European Patent Office (EPO)B1
JP2012005485AJapanA
AT540978TAustriaT
ATE540978T1AustriaT1
DK1558648T3DenmarkT3
PT1558648EPortugalE
ES2380621T3SpainT3
SI1558648T1SloveniaT1
IL221193D0This recordIsraelD0
KR20120128151ARepublic of KoreaA
JP5155968B2JapanB2
PL402418A1PolandA1
US8529902B2United States of AmericaB2
IL167851AIsraelA
KR101348472B1Republic of KoreaB1
LU92041I2LuxembourgI2
CN1729203BChinaB
US2014093454A1United States of AmericaA1
CN103709250AChinaA
PL216630B1PolandB1
CN101928344BChinaB
EP2330130B1European Patent Office (EPO)B1
ES2524694T3SpainT3
PL218660B1PolandB1
EA201492217A1Eurasian Patent Organization (EAPO)A1
CY1112750T1CyprusT1
CY2012019I1CyprusI1
CY2012019I2CyprusI2
JP5767041B2JapanB2
EA021644B1Eurasian Patent Organization (EAPO)B1
UA109629C2UkraineC2
CN103709250BChinaB
EP2316856B1European Patent Office (EPO)B1
EP3284753A2European Patent Office (EPO)A2
EP3284753A3European Patent Office (EPO)A3
BRPI0315295B1BrazilB1
LU92041I9LuxembourgI9
CA2502552CCanadaC
EP3284753B1European Patent Office (EPO)B1
BRPI0315295B8BrazilB8
ES2744275T3SpainT3
HUE046695T2HungaryT2
PT3284753TPortugalT
LT3284753TLithuaniaT
US2020317799A1United States of AmericaA1
BRPI0315295C1BrazilC1
DK3284753T3DenmarkT3
LTPA2021514I1LithuaniaI1
HUS2100026I1HungaryI1
FR21C1028I1FranceI1
LTC3284753I2LithuaniaI2
CA3029035CCanadaC